Clinical Trials Browser

Completed × Thyroid Neoplasms × anlotinib × Clear all

NCT06367010 2024-04-16

Clinical Efficacy of 125I Brachytherapy Combined With Anlotinib in Radioiodine Refractory Thyroid Carcinoma Patients

Thyroid Neoplasms